Efficacy and safety study of GSK1278863 in Japanese hemodialysis subjects with anemia associated with chronic kidney disease who are not taking erythropoiesis stimulating agents

Trial Identifier: 204716
Sponsor: GlaxoSmithKline
Start Date: August 2016
Primary Completion Date: May 2017
Study Completion Date: October 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Aichi, Japan, 457-8511
Japan Aichi, Japan, 455-8530
Japan Fukuoka, Japan, 802-8555
Japan Hokkaido, Japan, 065-8611
Japan Ibaraki, Japan, 300-0028
Japan Ibaraki, Japan, 306-0433
Japan Ibaraki, Japan, 302-0022
Japan Kagoshima, Japan, 891-0105
Japan Kumamoto, Japan, 861-8520
Japan Kyoto, Japan, 613-0034
Japan Mie, Japan, 510-8101
Japan Nagano, Japan, 399-8292
Japan Nagano, Japan, 392-8510
Japan Oita, Japan, 870-0844
Japan Osaka, Japan, 555-0001
Japan Shiga, Japan, 523-0082
Japan Yamagata, Japan, 990-0834